Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$0.62 - $0.79 $619 - $789
-999 Reduced 7.57%
12,190 $9,000
Q1 2023

May 09, 2023

SELL
$0.41 - $0.86 $10,503 - $22,032
-25,619 Reduced 66.01%
13,189 $10,000
Q4 2022

Feb 10, 2023

BUY
$0.36 - $1.59 $9,438 - $41,688
26,219 Added 208.27%
38,808 $15,000
Q3 2022

Nov 10, 2022

BUY
$1.26 - $2.09 $601 - $996
477 Added 3.94%
12,589 $18,000
Q2 2022

Aug 15, 2022

BUY
$0.97 - $3.08 $8,955 - $28,434
9,232 Added 320.56%
12,112 $15,000
Q1 2022

May 12, 2022

SELL
$2.55 - $5.23 $64,611 - $132,517
-25,338 Reduced 89.79%
2,880 $8,000
Q4 2021

Feb 14, 2022

BUY
$4.43 - $8.33 $118,936 - $223,643
26,848 Added 1959.71%
28,218 $125,000
Q3 2021

Nov 15, 2021

SELL
$6.07 - $9.89 $52,244 - $85,123
-8,607 Reduced 86.27%
1,370 $10,000
Q2 2021

Aug 16, 2021

BUY
$9.76 - $14.15 $30,168 - $43,737
3,091 Added 44.89%
9,977 $97,000
Q1 2021

May 17, 2021

BUY
$7.66 - $13.38 $40,950 - $71,529
5,346 Added 347.14%
6,886 $81,000
Q4 2020

Feb 16, 2021

SELL
$6.1 - $7.94 $34,391 - $44,765
-5,638 Reduced 78.55%
1,540 $12,000
Q3 2020

Nov 16, 2020

SELL
$6.52 - $8.94 $5,607 - $7,688
-860 Reduced 10.7%
7,178 $49,000
Q2 2020

Aug 13, 2020

BUY
$6.18 - $10.76 $17,668 - $30,762
2,859 Added 55.2%
8,038 $61,000
Q1 2020

May 15, 2020

BUY
$6.03 - $15.24 $27,496 - $69,494
4,560 Added 736.67%
5,179 $33,000
Q4 2019

Feb 07, 2020

SELL
$9.07 - $15.84 $5,414 - $9,456
-597 Reduced 49.1%
619 $9,000
Q3 2019

Nov 05, 2019

BUY
$9.63 - $14.0 $10,467 - $15,218
1,087 Added 842.64%
1,216 $12,000
Q2 2019

Aug 13, 2019

SELL
$13.4 - $17.67 $8,884 - $11,715
-663 Reduced 83.71%
129 $2,000
Q1 2019

May 14, 2019

BUY
$5.7 - $19.7 $3,323 - $11,485
583 Added 278.95%
792 $13,000
Q4 2018

Feb 14, 2019

SELL
$5.57 - $11.65 $1,687 - $3,529
-303 Reduced 59.18%
209 $1,000
Q3 2018

Nov 13, 2018

BUY
$11.32 - $15.7 $5,795 - $8,038
512 New
512 $6,000

Others Institutions Holding MGTA

About Magenta Therapeutics, Inc.


  • Ticker MGTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,890,500
  • Description
  • Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...
More about MGTA
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.